Objectives: The role of adipsin and adipsin Hinc II polymorphisms on the metabolic and body composition changes in response to overfeeding was studied. Subjects: A total of 12 pairs of male monozygotic twins ate a 4.2 MJ/day energy surplus, 6 days a week, during a period of 100 days. Results: The preoverfeeding plasma adipsin concentration correlated positively with the change in CT-measured abdominal total and subcutaneous (Po0.05) fat. The changes in abdominal total fat and abdominal subcutaneous fat correlated negatively with changes in plasma adipsin concentrations (Po0.005). Overfeeding induced greater increases in body weight, fat mass, abdominal total and subcutaneous fat (Po0.05) in 6.1 kb noncarriers (n ¼ 10) than in 6.1 kb carriers (n ¼ 14) of the adipsin Hinc II polymorphism. The 6.1 kb noncarriers had a greater increase in plasma leptin levels (Po0.01). Also the total (Po0.01) and very-low-density lipoprotein (VLDL)-triglycerides (Po0.05), apolipoprotein B (Po0.05) and VLDL-cholesterol (Po0.05) levels increased more in the 6.1 kb noncarriers than in the 6.1 kb carriers. Conclusions: Adipsin plasma level could be a predictor of the changes in abdominal subcutaneous fat during times of increased energy intake. However, a greater increase in the abdominal subcutaneous fat was related to a lower increase in the plasma adipsin level. The adipsin Hinc II 6.1 kb allele noncarriers gained more abdominal subcutaneous fat and had a greater increase in plasma levels of leptin-and triglyceride-rich lipoproteins when exposed to a long-term positive energy balance. These findings provide new information on the role of adipsin on individual differences in response to chronically elevated food intake.
Introduction
Adipose tissue is an important component not only of the body's regulatory system of energy balance, but is also an endocrine organ involved in complex metabolic functions and secreting a large number of proteins (Ahima & Flier, 2000) . Among them, adipsin is identical to complement factor D (White et al, 1992) and is a component of the alternative pathway of complement activation (Müller-Eberhard, 1988 ). This pathway is important in the natural defense against infectious agents. Adipsin/complement factor D is present in high amounts in adipose tissue indicating that complement activation occurs in adipose tissue (Müller-Eberhard, 1988) . Therefore, adipsin and the alternative complement pathway may play a role in the regulation of systemic energy balance (Choy et al, 1992) . Low adipsin levels have been observed in several rodent models of obesity (Rosen et al, 1989) , which has been suggested to be a secondary phenomenon (Dugail et al, 1990) . In contrast, in humans, the concentrations of adipsin tend to be elevated in obesity state or in increased adiposity (Napolitano et al, 1994) . Genes encoding proteins that are regulators of energy balance are likely involved in the modulation of the response to environmental pressures causing weight gain. Recently, adipsin mRNA was significantly induced in fatty livers of mice in response to high-fat feeding (Gregoire et al, 2002) . Therefore, the aim of the present study was to assess the role of an adipsin gene polymorphism on metabolic and body composition changes observed in response to a long-term (100 days) overfeeding protocol conducted with 12 pairs of monozygotic twins.
Methods
The specific aims, study design, and methodology have been previously described in detail (Bouchard et al, 1990) . Briefly, 24 sedentary young men (mean (7s.d.) age, 2172 y) who constituted 12 pairs of healthy identical twins were studied. Each man gave written consent for participation in this study, which was approved by the Laval University Medical Ethics Committee and the Office for Protection from Research Risks of the National Institutes of Health, Bethesda, MD. The men were housed in a closed section of a dormitory on the campus of Laval University, Quebec, Canada. Each man stayed in the unit for 120 consecutive days: 14 days for baseline testing for habitual daily energy intake, 3 days for testing before the period of overfeeding, 100 days for the period of overfeeding, and 3 days for testing after the period of overfeeding. During the period of overfeeding, the men were fed a diet containing 4.2 MJ (1000 kcal) per day above their measured baseline energy intake, 6 days a week, for 100 days. On the seventh day of each week, they consumed their habitual daily energy intake. The food consumed each day had the following prescribed nutrient composition: 50% carbohydrate, 35% fat, and 15% protein. The men ate three meals per day plus an evening snack tailored to complete the daily prescription for energy intake.
Phenotype measurements
The body-mass index (BMI) was calculated as body weight (in kilograms) divided by height (in meters squared). Body density was determined by underwater weighing, and percentage fat was calculated with a standard equation (Bouchard et al, 1990) . Abdominal CT scanning was performed before and after the overfeeding period with a Siemens Somatom DRH scanner (Erlangen, Federal Republic of Germany) as reported earlier (Bouchard et al, 1990) . The skinfold thickness was measured at eight sites (biceps, triceps, front midthigh, medial calf, subscapular, suprailiac, abdominal, and midaxillary) according to the procedures recommended at the Airlie Conference (Lohman et al, 1988) . On the first 2 days of the 3-day test period, before the overfeeding period, blood samples were obtained in the morning after an overnight fast for the determination of total-, low-density lipoprotein (LDL)-, very-low-density lipoprotein (VLDL)-and high-density lipoprotein (HDL)-cholesterol, total-and VLDTG triglycerides, plasma glucose and insulin concentrations (Bouchard et al, 1996) . Apolipoprotein B concentration was measured in plasma by the rocket immunoelectrophoretic method (Laurell, 1966) . On day 2, a 75-g OGTT was performed. Blood samples were obtained every 15 min during the first hour and every 30 min during the next 2 h for the determination of plasma glucose and insulin. The same measurements were repeated during the 3-day test period after the overfeeding period. Plasma leptin was measured with an enzyme-linked immunosorbent assay specific for the human peptide (Wisse et al, 1999) . Plasma adipsin was measured by an ELISA assay. The blood-sampling regimen for leptin and adipsin analyses was the same as that used for plasma lipids.
Genetic analyses
Genomic DNA was isolated from permanent lymphoblastoid cell lines (Neitzel, 1986) , by proteinase K and phenol/ chloroform extraction procedure followed by dialysis and ethanol precipitation. The human adipsin cDNA probe was obtained from Metabolic Biosystems Inc. ('Meta Bio', Mountain View, CA, USA). Samples of 5 mg of DNA were digested with 40 restriction enzymes under conditions recommended by the manufacturer (New England Biolabs, Beverly, MA, USA). Southern blot analysis was performed as described earlier (Ukkola et al, 2000) . One restriction fragment length polymorphism (RFLP) was uncovered with the enzyme Hinc II. There was a fragment of 6.1 kb when no restriction site was present and two fragments of 3.5 and 2.6 kb, respectively, with the site. A second restriction site (B) was also present at 0.8 kb from the more polymorphic site (A). The latter site, when it disappeared, could give a fragment of 6.9 kb if site A was not present. The latter fragment was not, however, observed in this study.
Statistical analysis
Differences in phenotype (absolute) changes between adipsin genotypes were assessed by analysis of variance. Absolute changes were calculated from individual scores. Analyses were performed both with the 24 subjects considered as unrelated persons and with the phenotype mean of each of the 12 pairs. Statistical analyses were performed with the SAS statistical package (SAS institute, Cary, NC, USA).
Results
Changes in body weight and measures of body composition with overfeeding in the Quebec Overfeeding Study have been reported previously for the 12 pairs of twins (Bouchard et al, 1990 ) and will not be detailed here. In the whole cohort, the preoverfeeding plasma adipsin concentration correlated negatively with the variation in adipsin in response to overfeeding (r ¼ À0.79; Po0.0001), and positively with the change in abdominal subcutaneous or total fat (Po0.05) ( Table 1 ). The changes in abdominal total fat and abdominal subcutaneous fat correlated negatively with the change in plasma adipsin concentrations (Pr0.005) ( Table 1) . Plasma lipids did not show any correlation with adipsin levels (not shown). Plasma leptin changes in response to overfeeding correlated positively with the changes in abdominal total (r ¼ 0.61; P ¼ 0.001) and abdominal subcutaneous (r ¼ 0.42; P ¼ 0.041) fat.
In the 6.1/6.1 kb subjects (n ¼ 4), the phenotype changes in response to overfeeding were similar to those in the 6.1/ 3.5 kb subjects (n ¼ 10). Therefore, the 6.1/6.1 kb subjects were pooled together with the 6.1/3.5 kb subjects in all the analyses for the purpose of comparison. Table 2 shows the effect of overfeeding on body composition, total subcutaneous and abdominal fat. Before overfeeding, adipsin 3.5/ 3.5 kb (6.1 kb allele noncarriers) subjects had higher body weight (Po0.05), fat mass (Po0.05), total subcutaneous fat (Po0.01), abdominal subcutaneous (Po0.01), visceral (Po0.01), and total fat (Po0.01) than those with 6.1/ 6.1+6.1/3.5 kb genotypes (6.1 kb allele carriers). Overfeeding induced greater increases in body weight, fat mass, total subcutaneous, and abdominal subcutaneous fat (Po0.05) in the 6.1 kb noncarriers than in the 6.1 kb carriers. Thus, after overfeeding the differences in body weight, fat mass, total subcutaneous fat, and total and subcutaneous abdominal fat areas between the 6.1 kb noncarriers and 6.1 kb carriers were more prominent than before the caloric surplus (Table 2) .
Fasting plasma leptin, adipsin, and insulin levels as well as OGTT glucose and insulin areas by adipsin Hinc II genotypes are shown in Table 3. The fasting plasma leptin level before (Po0.05) and after (Po0.01) overfeeding was higher among subjects who were 6.1 kb allele noncarriers than those who were 6.1 kb allele carriers. In addition, 6.1 kb noncarriers had a greater increase in plasma leptin levels in response to overfeeding (Po0.01). Adipsin Hinc II 6.1 kb allele noncarriers had higher total, LDL-and VLDL-cholesterol, apolipoprotein B, and total and VLDL-triglycerides (P from o0.05 to o0.01) than 6.1 kb allele carriers before and after overfeeding (Table 4) . In response to overfeeding, total (Po0.01) and VLDL-triglycerides (Po0.05), apolipoprotein B (Po0.05), and VLDL-cholesterol (Po0.05) increased more in the 6.1 kb noncarriers than in the 6.1 kb carriers.
When the changes of different phenotypes were adjusted for their baseline values, the increases in abdominal subcutaneous fat (P ¼ 0.041), abdominal total fat area (P ¼ 0.008), and total cholesterol (P ¼ 0.031) as well as the decrease in HDL-cholesterol (P ¼ 0.035) were significantly greater among 6.1 kb allele noncarriers than carriers.
Discussion
The expression of adipsin is suppressed both in db/db and ob/ob mice and fa/fa rats (Rosen et al, 1989) , which has been suggested to be a secondary phenomenon and not significant in the etiology of obesity (Dugail et al, 1990) . In contrast to rodents, plasma adipsin levels are high in human obesity . In the present study, the baseline Adipsin gene and overfeeding O Ukkola et al adipsin level was not related to indicators of fat topography. However, the initial plasma adipsin concentration correlated positively with the changes in abdominal subcutaneous fat and total fat area in response to overfeeding. The latter suggests that a high adipsin concentration before overfeeding predicts gain in abdominal fat during overfeeding. In mice, restriction of energy intake increased serum adipsin levels (Spurlock et al, 1996) . Body weight changes correlate with changes in serum levels of complement proteins (Pomeroy et al, 1997) in humans as well. Interestingly, the present data suggested that a greater increase in abdominal subcutaneous fat induced by overfeeding was related to a lower increase in plasma adipsin level.
In the present study, the adipsin Hinc II polymorphism, whose functional significance and exact site are yet unknown, was associated with body composition changes in response to the caloric surplus. Adipsin Hinc II 6.1 kb allele noncarriers, who registered a slightly higher gain in body weight but a considerably higher increase in abdominal total and subcutaneous fat areas, experienced less increase in plasma adipsin levels, although the latter change did not reach statistical significance. The 6.1 kb allele noncarriers experienced also a greater increase in TG-rich lipoproteins and apolipoprotein B in response to overfeeding. The interaction of adipsin, factor B, and third component of complement, all three of which are synthesized in adipose tissue, generates acylation stimulating protein (ASP) . Therefore, the concentration of adipsin may be related to the concentration of ASP and the effects of adipsin on adipose tissue metabolism may be mediated through the generation of ASP. The data of the present study suggest that different adipose tissue depots may manifest Values are means (s.e.). P-values based on 24 subjects considered as unrelated persons were as follows: *Pr0.05, **Pr0.01, and ***Pr0.0005 between 6.1 kb allele carriers and noncarriers. P values when phenotype means of each pair are compared (n=12) are as follows: *Po0.05 for the changes in sum of eight skinfolds and abdominal subcutaneous fat, others nonsignificant; **Po0.05 for postoverfeeding sum of eight skinfolds, preoverfeeding abdominal total and subcutaneous fat; ***Po0.01 postoverfeeding abdominal total and subcutaneous fat. Values are means (s.e.). P-values based on 24 subjects considered as unrelated persons were as follows: *Pr0.05 and **Pr0.01 between 6.1 kb allele carriers and noncarriers. P-values when phenotype means of each pair are compared (n=12) are as follows: *not significant, **Pr0.05.
different activities of the ASP pathway. Earlier data suggested that mice lacking ASP have delayed clearance of triglycerides because fatty acid trapping by adipocytes is reduced (Murray et al, 1999) . The latter leads to excessive delivery of dietary fatty acids to liver with an ensuing increase in the secretion of apoB-100 lipoproteins (Murray et al, 1999) . In addition, ASP is a potent stimulator of triglyceride synthesis (Yasruel et al, 1991) and fat storage in adipocytes. Thus, dysregulation of ASP pathway, caused by a genetic alteration, perhaps in adipsin, may have important metabolic consequences, like hypertriglyceridemia, obesity, and cardiovascular disease . It must be pointed out, however, that the full significance of circulating adipsin remains unknown. Leptin is produced by subcutaneous adipose tissue (Montague et al, 1997). In the current study, plasma leptin changes in response to overfeeding correlated positively with the changes in total and abdominal subcutaneous fat. Therefore, the finding that plasma leptin levels increased more among noncarriers of the adipsin Hinc II 6.1 kb allele, who also had the greatest increase in abdominal subcutaneous fat, is not unexpected. However, in contrast to leptin, adipsin did not show any differences in gene expression between subcutaneous and visceral adipocytes in a recent study (Montague et al, 1998) .
In conclusion, the data of this study suggest that adipsin plasma level could be a predictor of the changes in subcutaneous fat during times of increased energy intake. However, a greater increase in abdominal subcutaneous fat induced by overfeeding was related to an attenuated increase in adipsin level. Adipsin Hinc II 6.1 kb allele noncarriers were those who gained more total and subcutaneous abdominal fat and increased more their plasma levels of leptin, apolipoprotein B, and triglyceride-rich lipoproteins when they were exposed to a long-term positive energy balance. These findings provide new information on the role of plasma adipsin and a molecular marker of the adipsin gene on individual differences in response to chronically elevated food intake. Values are means (s.e.). P-values based on 24 subjects considered as unrelated persons were as follows: *Pr0.05 and **Pr0.01 between 6.1 kb allele carriers and noncarriers. P-values when phenotype means of each pair are compared (n=12) were as follows: *not significant, **Pr0.05 for postoverfeeding total and LDL cholesterol and total triglycerides as well as for preoverfeeding apolipoprotein B, P=0.004 for postoverfeeding apolipoprotein B, others were not significant.
